Hester Biosciences Ltd. share price target and research reports

Name: Latest research reports of Hester Biosciences Ltd. authored by Karvy and published by - Trendlyne research reports.
Item: Hester Biosciences Ltd.
Rating: 5
Author: Karvy

Latest analyst research reports with target prices and PDF download for HESTERBIO, BSE:524669 Hester Biosciences Ltd.

Hester Biosciences Ltd.

28 Aug 2015

1768.60

1.20%

Hester Biosciences Ltd: Rising Star in Animal Healthcare Business (Aug 28, 2015)

Buy: Hester Biosciences Ltd.

Karvy

PPR Eradication Program by FAO - A Tremendous Opportunity for Hester: Food and Agriculture Organization (FAO) has embarked on a mission to eradicate PPR disease (plague affecting Sheep and Goats) and has planned to spend about US$ 7.6 Bn over a span of 15 years starting 2015. Annual spend on PPR vaccines will be about US$ 0.5 Bn in the initial stages. This is a tremendous opportunity and HBL (Hester Biosciences Ltd.) has already set up a plant in Nepal to manufacture and export PPR vaccines worldwide. Nepal plant is expected to start operations in Oct 2015. Hester has already begun establishing cold storage and distribution networks, the backbone of vaccines business, across southern and eastern Africa. International manufacturers have priced the vaccine at 10 US cents per dose, but Hester would be aggressively pricing between 2.5 to 3.5 US cents.

Hester Biosciences Ltd. is trading above its 50 day SMA of 1601.1

Is Hester Biosciences Ltd. worth buying?

80 Votes:

Buy 80.0%

Sell 11.25%

Hold 8.75%